Amal Elkordy

2.4k total citations · 1 hit paper
69 papers, 1.9k citations indexed

About

Amal Elkordy is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Amal Elkordy has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmaceutical Science, 26 papers in Molecular Biology and 15 papers in Materials Chemistry. Recurrent topics in Amal Elkordy's work include Drug Solubulity and Delivery Systems (29 papers), Advanced Drug Delivery Systems (21 papers) and Protein purification and stability (14 papers). Amal Elkordy is often cited by papers focused on Drug Solubulity and Delivery Systems (29 papers), Advanced Drug Delivery Systems (21 papers) and Protein purification and stability (14 papers). Amal Elkordy collaborates with scholars based in United Kingdom, Egypt and Saudi Arabia. Amal Elkordy's co-authors include Temidayo Olusanya, James R. Smith, Madu Daniel Ibegbu, Ebtessam A. Essa, Cheng Shu Chaw, Brian Barry, Robert T. Forbes, Randa Mohammed Zaki, Ahmed Faheem and Amani S. Awaad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Amal Elkordy

64 papers receiving 1.8k citations

Hit Papers

Liposomal Drug Delivery Systems and Anticancer Drugs 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal Elkordy United Kingdom 22 746 609 425 291 290 69 1.9k
Hyeongmin Kim South Korea 17 909 1.2× 463 0.8× 401 0.9× 265 0.9× 305 1.1× 43 2.2k
Fatemeh Sadeghi Iran 27 947 1.3× 450 0.7× 640 1.5× 402 1.4× 320 1.1× 65 2.1k
Bappaditya Chatterjee India 25 975 1.3× 394 0.6× 331 0.8× 237 0.8× 173 0.6× 78 2.1k
Myung Joo Kang South Korea 26 850 1.1× 469 0.8× 394 0.9× 197 0.7× 140 0.5× 109 1.9k
Xia Lin China 26 726 1.0× 931 1.5× 475 1.1× 398 1.4× 410 1.4× 67 2.6k
Amber Vyas India 19 781 1.0× 594 1.0× 531 1.2× 355 1.2× 384 1.3× 65 2.0k
Jin‐Ki Kim South Korea 32 1.1k 1.5× 978 1.6× 549 1.3× 326 1.1× 274 0.9× 82 2.9k
Xing Tang China 27 1.3k 1.8× 496 0.8× 325 0.8× 165 0.6× 376 1.3× 84 2.1k
Shinji Sakuma Japan 29 1.1k 1.4× 713 1.2× 402 0.9× 249 0.9× 271 0.9× 103 2.4k
Rajeev Gokhale United States 19 981 1.3× 363 0.6× 294 0.7× 271 0.9× 304 1.0× 37 1.8k

Countries citing papers authored by Amal Elkordy

Since Specialization
Citations

This map shows the geographic impact of Amal Elkordy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Elkordy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Elkordy more than expected).

Fields of papers citing papers by Amal Elkordy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal Elkordy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Elkordy. The network helps show where Amal Elkordy may publish in the future.

Co-authorship network of co-authors of Amal Elkordy

This figure shows the co-authorship network connecting the top 25 collaborators of Amal Elkordy. A scholar is included among the top collaborators of Amal Elkordy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal Elkordy. Amal Elkordy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amer, Asem A., et al.. (2025). Fast-Disintegrating Oral Films Containing Nisin-Loaded Niosomes. Molecules. 30(18). 3715–3715. 1 indexed citations
2.
Amer, Ibrahim, et al.. (2025). Flexipill: A novel 3D printed personalised analgesic polypill with diverse targeted drug release approaches. Journal of Drug Delivery Science and Technology. 108. 106882–106882. 1 indexed citations
3.
Amer, Asem A., Lewis Bingle, Amal Elkordy, & Cheng Shu Chaw. (2025). Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms. Biomedicines. 13(11). 2735–2735.
5.
Elkordy, Amal, et al.. (2024). Liposomes and Their Therapeutic Applications in Enhancing Psoriasis and Breast Cancer Treatments. Nanomaterials. 14(21). 1760–1760. 4 indexed citations
6.
Paget, Timothy A., et al.. (2024). Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy. Pharmaceutics. 16(9). 1123–1123. 6 indexed citations
7.
Elkordy, Amal, et al.. (2024). Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease. Journal of Taibah University Medical Sciences. 19(3). 549–565. 8 indexed citations
8.
Essa, Ebtessam A., et al.. (2024). A glance into factors affecting the possible combined entrapment of curcumin and methylene blue into niosomal formulations as a potential anticancer therapy. Journal of Drug Delivery Science and Technology. 100. 106120–106120. 1 indexed citations
9.
Elkordy, Amal, Rita Haj‐Ahmad, Amani S. Awaad, & Randa Mohammed Zaki. (2021). An overview on natural product drug formulations from conventional medicines to nanomedicines: Past, present and future. Journal of Drug Delivery Science and Technology. 63. 102459–102459. 83 indexed citations
11.
Chaw, Cheng Shu, et al.. (2019). The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method. Pharmaceuticals. 12(2). 46–46. 49 indexed citations
12.
Carr‐Wilkinson, Jane, et al.. (2018). Insights into the Influences of Carboxymethyl-β-Cyclodextrin on DNA Formulations Characteristics and Gene Transfection Efficiency. Current Drug Delivery. 15(6). 867–878. 4 indexed citations
13.
Paget, Timothy A., et al.. (2016). Formulation and advantages of furazolidone in liposomal drug delivery systems. European Journal of Pharmaceutical Sciences. 84. 139–145. 23 indexed citations
14.
Elkordy, Amal, et al.. (2015). Design and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug. Drug Design Development and Therapy. 9. 1843–1843. 33 indexed citations
15.
Elkordy, Amal, et al.. (2015). In vitro characterisation of Span™ 65 niosomal formulations containing proteins. Current Drug Delivery. 12(5). 628–639. 15 indexed citations
16.
Crum, Matthew, et al.. (2012). In situlyophilisation of nifedipine directly in hard gelatine capsules. Pharmaceutical Development and Technology. 18(6). 1379–1390. 4 indexed citations
17.
Elkordy, Amal, et al.. (2012). In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide. International Journal of Pharmaceutics. 428(1-2). 118–120. 19 indexed citations
18.
Elkordy, Amal & Ebtessam A. Essa. (2010). Effects of Spray Drying and Spray Chilling on Ibuprofen Dissolution. Iranian journal of pharmaceutical sciences. 6(1). 3–12. 4 indexed citations
19.
Holyoake, Tessa L., et al.. (2009). TNF Polymorphisms Independently Predict Outcome in Patients with B-Cell Non-Hodgkin’s Lymphoma. Sunderland Repository (University of Sunderland). 2(1). 19–27. 1 indexed citations
20.
Elkordy, Amal, et al.. (2009). Characterisation of spray-dried naproxen formulations. Sunderland Repository (University of Sunderland). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026